Terms: = Skin cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Diagnosis
6 results:
1. Dermatological toxicity associated with targeted therapies in cancer: optimal management.
Peuvrel L; Dréno B
Am J Clin Dermatol; 2014 Oct; 15(5):425-44. PubMed ID: 25117153
[TBL] [Abstract] [Full Text] [Related]
2. Mechanistic basis of desmosome-targeted diseases.
Al-Jassar C; Bikker H; Overduin M; Chidgey M
J Mol Biol; 2013 Nov; 425(21):4006-22. PubMed ID: 23911551
[TBL] [Abstract] [Full Text] [Related]
3. Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
Krejsgaard T; Vetter-Kauczok CS; Woetmann A; Kneitz H; Eriksen KW; Lovato P; Zhang Q; Wasik MA; Geisler C; Ralfkiaer E; Becker JC; Ødum N
Blood; 2009 Jun; 113(23):5896-904. PubMed ID: 19351960
[TBL] [Abstract] [Full Text] [Related]
4. Targeting intracellular signaling pathways as a novel strategy in melanoma therapeutics.
Smalley KS; Herlyn M
Ann N Y Acad Sci; 2005 Nov; 1059():16-25. PubMed ID: 16382039
[TBL] [Abstract] [Full Text] [Related]
5. Receptor tyrosine kinase and p16/CDKN2 expression in a case of tripe palms associated with non-small-cell lung cancer.
Krähn G; Greulich KM; Bezold G; Dieterle C; Wolff H; Peter RU
Dermatology; 1999; 199(4):290-5. PubMed ID: 10640836
[TBL] [Abstract] [Full Text] [Related]
6. Amplification of N-myc oncogene in human melanoma cells.
Bauer J; Sokol L; Stríbrná J; Kremen M; Krajsová I; Hausner P; Hejnar P
Neoplasma; 1990; 37(3):233-8. PubMed ID: 2370914
[TBL] [Abstract] [Full Text] [Related]
